JOURNAL ARTICLE

PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment

Xian TangJingdong RaoSheng YinJiaojie WeiChunyu XiaMan LiLing MeiZhirong ZhangQin He

Year: 2018 Journal:   European Journal of Pharmaceutical Sciences Vol: 127 Pages: 161-174   Publisher: Elsevier BV
Keywords:
Immunogenic cell death Paclitaxel Cancer research PI3K/AKT/mTOR pathway Cytotoxic T cell Cell cycle checkpoint Cell cycle Cancer cell Gene knockdown Immunity Chemistry Immune checkpoint Melanoma Programmed cell death Cancer Immune system Biology Apoptosis Immunotherapy Immunology In vitro Biochemistry

Metrics

34
Cited By
1.70
FWCI (Field Weighted Citation Impact)
49
Refs
0.80
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Immunotherapy and Immune Responses
Life Sciences →  Immunology and Microbiology →  Immunology
Cancer Immunotherapy and Biomarkers
Health Sciences →  Medicine →  Oncology
Nanoplatforms for cancer theranostics
Physical Sciences →  Engineering →  Biomedical Engineering

Related Documents

JOURNAL ARTICLE

Melanoma Cancer Immunotherapy Using PD-L1 siRNA and Imatinib Promotes Cancer-Immunity Cycle

Chenyang LiXiuping Han

Journal:   Pharmaceutical Research Year: 2020 Vol: 37 (6)Pages: 109-109
JOURNAL ARTICLE

ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer

Hui MengYi DingEnjie LiuWencai LiLiang Wang

Journal:   Translational Oncology Year: 2020 Vol: 14 (2)Pages: 101003-101003
© 2026 ScienceGate Book Chapters — All rights reserved.